Cite

HARVARD Citation

    Asghar, S. et al. (2022). Interim MRI in HER2-positive breast cancer patients receiving neoadjuvant chemotherapy. European journal of surgical oncology. 48 (5), pp. e235-e236. [Online]. 
  
Back to record